SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: MCHM transdermal gel drug delivery

No earlier versions found for this Subject.


Return to MCHM transdermal gel drug delivery
 
Hi! Does anyone have any info on MCHM (Macrochem). Apparently they are working on numerous transdermal pharmaceutical applications, especially TD (transdermal) alprostadil (prostaglandine e1) -- the same substance as VIVUS and HVSF for male erectile dysfunction. They are also working on TD testosterone and TD NSAIDs (I think ibuprofen). Their market cap seems very small compared to their potential sales, but of course, their products are still in development. Any thoughts?

-- Roger

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News